Related Experiment Video
Updated: Jun 25, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Quantitative Three-Dimensional Transesophageal Echocardiography Analysis of Mitral Valve Geometry for Transcatheter
Kuan-Chih Huang1, Jeremy J Thaden2, Ghasaq Saleh2
1Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota; Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital Hsinchu Branch, Hsinchu, Taiwan.
Background:
Atrial functional mitral regurgitation (AFMR) is a distinct subtype of secondary mitral regurgitation (MR) in patients with atrial fibrillation (AF). Although mitral transcatheter edge-to-edge repair (M-TEER) is increasingly performed under three-dimensional (3D) transesophageal echocardiography (TEE) guidance, detailed characterization of 3D mitral valve geometry relevant to procedural strategy remains limited.
Objectives:
To investigate the impact of mitral valve geometrical parameters on preprocedural planning and outcomes of M-TEER in AFMR.
Methods:
Patients with AFMR undergoing M-TEER with analyzable intraprocedural 3D TEE data were retrospectively enrolled. We evaluated whether the total leaflet area to mitral annulus area ratio (TLA/MAA) was associated with procedural strategy (1 vs 2 devices) and procedural failure, defined as residual MR ≥ 2+ and/or postprocedural transmitral mean pressure gradient (MPG) ≥ 5 mm Hg.
Results:
Among 130 patients (mean age, 78.1 years; 60.8% male; 93.4% AF), residual MR ≥ 2+ occurred in 31 patients and post-M-TEER MPG ≥ 5 mm Hg in 35 patients. Thirty patients received 2 devices. Lower TLA/MAA was associated with residual MR ≥ 2+, use of 2 devices, and postprocedural MPG ≥ 5 mm Hg. Under the composite definition of procedural success (MR < 2+ and MPG < 5 mm Hg), TLA/MAA outperformed MAA in predicting success with 1 device (area under the curve = 0.79 vs 0.53; P < .001).
Conclusions:
In AFMR, 3D TEE-derived TLA/MAA can provide geometrical information to guide preprocedural M-TEER strategy to balance MR reduction and transmitral gradient.
Related Concept Videos
Mitral Regurgitation III: Medical Management
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Valve Prolapse II: Assessment and Management
Mitral Stenosis III: Medical Management
Mitral Regurgitation I: Introduction
